Patent · US Active

Dermatologic composition containing Escherichia coli and Enterococcus faecalis

US10933103B2 · kind B2 · utility

0Cited by

0References

18Claims

0Family size

Assignee

SymbioGruppe GmbH & Co. KG · DE

Inventors

Hans-Jorg Muller · Solms, DE
Thomas Schmidts · Gießen, DE
Kurt Zimmermann · Durham, US
Volker Rusch · Herborn, DE

Key dates

Filing date	Nov 28, 2018
Grant date	Mar 2, 2021
Priority date	—
Expiry date	Apr 12, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is a composition comprising an effective amount of a mixture of inactivated Escherichia coli and Enterococcus faecalis as well as pharmaceutically acceptable excipients and/or carriers for use in the treatment, supportive treatment or prevention of dermatologic conditions and diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.